Pages

▼
Saturday, October 19, 2019

TOL-3021 Starts A Phase-II Clinical Trial

›
TOL-3021 causes the body to generate proinsulin so that over time the immune system will get used to (or tolerate) it.  Proinsulin and insul...
2 comments:
Friday, October 11, 2019

JDRF Funding for a Cure 2019

›
In the US, we are in the "Walking Season" when JDRF (Juvenile Diabetes Research Foundation) asks us to walk to raise money for a ...
2 comments:
Saturday, September 28, 2019

Possible Cures for Type-1 in the News (September)

›
Unsuccessful  Phase-I Clinical Trial of Beta-O2's Encapsulated Beta Cells  Encapsulated beta cells are implanted devices.  The encap...
1 comment:
Thursday, September 19, 2019

Teplizumab Phase-II Results For Prevention And Starts A Phase-III On Honeymooners

›
As with previous years, the American Diabetes Association's annual scientific meeting is mostly about type-2 diabetes, and even the type...
Thursday, August 8, 2019

Personal Note

›
I've been very busy this summer, and so I only published one blog posting in May, one in June, and none in July or August.  I do plan to...
2 comments:
Tuesday, June 18, 2019

MER3101 Starts a Phase-I Clinical Trial

›
MER3101 is vaccine-like formulation of Insulin Beta Chain (IBC) and MAS-1, an adjuvant.   That makes more sense when you read it back to fro...
1 comment:
Wednesday, May 1, 2019

Possible Cures for Type-1 in the News (May)

›
This blog posting contains two different new items, with a short note on each: The One That Got Away The first article covers some work ...
2 comments: